Tag Archives: market authorization

A Fine Line Between Regulation and Evolution

The strict regulatory divide between market authorization and price reimbursement is crumbling in the US. Ansis Helmanis asks — is industry prepared to adapt or challenge? On September 17, the FDA and CMS jointly issued a Federal Register (FR) notice that they were establishing a process for overlapping evaluations of premarket, FDA-regulated medical products when […]
Posted in FDA, Market Access, Regulatory | Also tagged , , , | Leave a comment
  • Categories

  • Meta